×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Biomaterial Market

ID: MRFR/HC/48469-HCR
200 Pages
Garvit Vyas
February 2026

India Biomaterial Market Research Report: By Application (Medical Devices, Tissue Engineering, Drug Delivery, Orthopedics, Wound Care), By Type (Natural Biomaterials, Synthetic Biomaterials, Modified Biomaterials), By Source (Plant-based, Animal-based, Microbial-based) andBy End Use (Healthcare, Pharmaceuticals, Cosmetics) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Biomaterial Market Infographic
Purchase Options

India Biomaterial Market Summary

As per Market Research Future analysis, the India biomaterial market Size was estimated at 4715.4 USD Million in 2024. The India biomaterial market is projected to grow from 5084.14 USD Million in 2025 to 10796.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India biomaterial market is poised for substantial growth driven by sustainability and innovation.

  • Sustainable packaging solutions are gaining traction as consumers increasingly prefer eco-friendly products.
  • Advancements in medical applications are expanding the use of biomaterials in healthcare, particularly in implants and drug delivery systems.
  • Government support and policy initiatives are fostering a favorable environment for biomaterial development and adoption.
  • Rising demand for eco-friendly products and technological innovations in biomaterials are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 4715.4 (USD Million)
2035 Market Size 10796.0 (USD Million)
CAGR (2025 - 2035) 7.82%

Major Players

BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), 3M Company (US), NatureWorks LLC (US), Genomatica Inc (US), Futerro (BE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Biomaterial Market Trends

The biomaterial market in India is currently experiencing a notable transformation, driven by increasing awareness of sustainable practices and the growing demand for eco-friendly materials. This shift is largely influenced by government initiatives aimed at promoting the use of renewable resources and reducing environmental impact. As industries seek alternatives to traditional materials, the adoption of biomaterials is becoming more prevalent across various sectors, including packaging, healthcare, and construction. The emphasis on innovation and research in this field is fostering the development of advanced biomaterials that offer enhanced performance and functionality. Moreover, the regulatory landscape is evolving to support the growth of the biomaterial market. Policies encouraging the use of biodegradable and compostable materials are gaining traction, which may lead to increased investments in research and development. The collaboration between academic institutions and industry players is likely to accelerate the introduction of novel biomaterials, further expanding the market's potential. As consumer preferences shift towards sustainable options, the biomaterial market appears poised for significant growth in the coming years, reflecting a broader trend towards environmental responsibility and sustainability.

Sustainable Packaging Solutions

The demand for sustainable packaging solutions is rising within the biomaterial market. Companies are increasingly seeking biodegradable and compostable materials to reduce their environmental footprint. This trend is driven by consumer preferences for eco-friendly products and regulatory pressures to minimize plastic waste. As a result, innovations in packaging materials derived from natural sources are gaining momentum.

Advancements in Medical Applications

The biomaterial market is witnessing advancements in medical applications, particularly in the development of biocompatible materials for implants and drug delivery systems. Research institutions and healthcare companies are collaborating to create materials that enhance patient outcomes and reduce the risk of complications. This trend reflects a growing focus on personalized medicine and the need for materials that can integrate seamlessly with biological systems.

Government Support and Policy Initiatives

Government support and policy initiatives are playing a crucial role in shaping the biomaterial market. Various programs aimed at promoting research and development in sustainable materials are being implemented. These initiatives not only encourage innovation but also provide financial incentives for companies investing in biomaterials. As a result, the market is likely to benefit from increased funding and resources dedicated to advancing biomaterial technologies.

India Biomaterial Market Drivers

Rising Demand for Eco-Friendly Products

The increasing consumer awareness regarding environmental sustainability is driving the demand for eco-friendly products in the biomaterial market. As consumers in India become more conscious of their ecological footprint, they are actively seeking alternatives to conventional materials. This shift is evident in various sectors, including packaging, textiles, and construction. The biomaterial market is poised to benefit from this trend, as it offers biodegradable and renewable options that align with consumer preferences. According to recent estimates, the market for biodegradable plastics alone is expected to grow at a CAGR of approximately 20% over the next five years. This growing demand for sustainable solutions is likely to propel innovation and investment in the biomaterial market, fostering a more sustainable economy in India.

Expanding Applications Across Industries

The versatility of biomaterials is leading to their expanding applications across various industries, which serves as a significant driver for the biomaterial market. From healthcare to packaging and construction, biomaterials are being integrated into diverse products and solutions. In the medical field, for instance, biomaterials are increasingly used in implants, drug delivery systems, and tissue engineering, reflecting a growing recognition of their benefits. Similarly, in the packaging sector, the shift towards sustainable materials is prompting companies to explore biomaterials as alternatives to traditional plastics. This broadening scope of applications is likely to attract new players to the biomaterial market, fostering competition and innovation. As industries continue to seek sustainable and efficient solutions, the biomaterial market is expected to experience robust growth in the coming years.

Technological Innovations in Biomaterials

Technological advancements play a crucial role in shaping the biomaterial market in India. Innovations in material science, such as the development of new biopolymers and composites, are enhancing the performance and applicability of biomaterials across various industries. For instance, the integration of nanotechnology in biomaterials is leading to improved mechanical properties and functionality, making them suitable for medical applications, packaging, and more. The Indian government has recognized the potential of these innovations, providing funding and support for research and development initiatives. As a result, the biomaterial market is likely to witness a surge in new product offerings, catering to diverse consumer needs and preferences. This technological evolution is expected to contribute significantly to the market's growth trajectory in the coming years.

Growing Investment in Research and Development

Investment in research and development (R&D) is a critical driver for the biomaterial market in India. As industries seek to develop innovative and sustainable materials, increased funding for R&D initiatives is essential. The Indian government, along with private sector players, is channeling resources into the exploration of new biomaterials and their applications. This focus on R&D is likely to yield breakthroughs that enhance the functionality and cost-effectiveness of biomaterials. Furthermore, collaborations between academic institutions and industry stakeholders are fostering knowledge transfer and accelerating the commercialization of new technologies. The emphasis on R&D is expected to position the biomaterial market as a key player in the broader materials industry, driving growth and sustainability.

Increasing Regulatory Support for Sustainable Practices

Regulatory frameworks in India are increasingly favoring sustainable practices, which is positively impacting the biomaterial market. The government has implemented various policies aimed at reducing plastic waste and promoting the use of biodegradable materials. For instance, the Plastic Waste Management Rules encourage the adoption of eco-friendly alternatives, thereby creating a conducive environment for the growth of the biomaterial market. Additionally, incentives for manufacturers adopting sustainable practices are likely to stimulate investment in biomaterials. As a result, the market is expected to expand, with more companies entering the sector to meet regulatory requirements and consumer demand for sustainable products. This regulatory support is anticipated to drive innovation and enhance the competitiveness of the biomaterial market in India.

Market Segment Insights

By Application: Medical Devices (Largest) vs. Tissue Engineering (Fastest-Growing)

The application segment within the India biomaterial market is dominated by Medical Devices, which holds a significant share of the market compared to other applications. This dominance can be attributed to the rising demand for advanced medical procedures that require biocompatible materials. Tissue Engineering, while smaller in current market share, is rapidly gaining traction and is on its way to becoming a major player in the market landscape. Growth trends in the application segment are being driven by advancements in technology and an increasing focus on patient-specific healthcare solutions. The surge in chronic diseases and the aging population are further pushing the need for effective wound care and drug delivery systems. With continuous investment in R&D, the market is poised for innovation, making it an exciting space for emerging applications like Tissue Engineering.

Medical Devices (Dominant) vs. Wound Care (Emerging)

Medical Devices represent the most substantial part of the application segment, characterized by a wide range of implants and surgical products that utilize biomaterials for enhanced functionality and patient safety. This category has seen consistent demand due to ongoing healthcare advancements and increased surgical interventions. On the other hand, Wound Care is emerging rapidly, fueled by an uptick in injuries and skin-related ailments. This segment focuses on innovative biomaterials that promote faster healing and reduce infection risks. As the healthcare landscape evolves, both segments are likely to play critical roles, with Medical Devices maintaining dominance while Wound Care continues to expand its share and relevance in the market.

By Type: Natural Biomaterials (Largest) vs. Synthetic Biomaterials (Fastest-Growing)

The distribution of market share among the types of biomaterials showcases a clear dominance of natural biomaterials due to their ecological advantages and compatibility with human biological systems. This segment has captured considerable attention owing to the growing consumer interest in sustainable and environmentally friendly products, outpacing other categories. In contrast, synthetic biomaterials, while capturing a smaller part of the market, are rapidly gaining traction due to advancements in technology that enhance performance and versatility. Growth trends in this segment reveal a significant shift towards innovative applications in diverse industries such as healthcare, packaging, and construction. The rising demand for biodegradable and eco-friendly materials is propelled by increasing environmental awareness, regulatory support, and heightened research and development efforts. Synthetic biomaterials are positioned as the fastest-growing variant, driven by their adaptability and tailored properties that meet specific industry needs.

Natural Biomaterials (Dominant) vs. Synthetic Biomaterials (Emerging)

Natural biomaterials are characterized by their origin from renewable biological resources, making them inherently sustainable and widely accepted in various applications. They dominate the market due to their superior biocompatibility and biodegradability, fostering a strong alignment with contemporary consumer preferences for green products. On the other hand, synthetic biomaterials represent a growing segment that is emerging as a competitive alternative, primarily driven by advancements in material science. They offer enhanced functionalities and can be engineered for specific purposes, appealing to sectors that require high-performance solutions, thus creating a balanced market landscape where both natural and synthetic options coexist and cater to differing consumer demands.

By Source: Plant-based (Largest) vs. Microbial-based (Fastest-Growing)

In the India biomaterial market, the market share distribution indicates that plant-based sources dominate, holding a significant portion of the overall market. This segment appeals to a growing consumer demand for sustainable and environmentally friendly solutions. Meanwhile, the animal-based segment maintains a stable presence but shows slower growth compared to the others, while microbial-based sources are beginning to catch up as novel applications and biotechnology enhance their viability. Growth trends within this segment are driven by several factors, including increasing investment in research and development aimed at improving the efficiency of production processes. Furthermore, the rising awareness of sustainability and eco-friendly products is propelling the demand for both plant-based and microbial-based biomaterials in various applications. Innovations in microbial processes and the development of fermentation technologies are contributing to the rapid growth of the microbial segment, positioning it as a critical area to watch in the coming years.

Plant-based (Dominant) vs. Microbial-based (Emerging)

The plant-based segment remains the dominant force within the India biomaterial market, characterized by a wide range of applications across industries such as packaging, textiles, and construction. Its success is attributed to consumer preference for renewable and biodegradable materials, which align with global sustainability trends. In contrast, the microbial-based segment, while classified as emerging, is rapidly gaining traction due to advancements in biotechnology that enhance production efficiency and reduce costs. This segment is well-positioned for future growth, particularly in applications that require unique properties such as biocompatibility and biodegradability, making it an exciting area for innovation and investment.

By End-use: Healthcare (Largest) vs. Pharmaceuticals (Fastest-Growing)

In the India biomaterial market, the end-use segment is led by healthcare, which commands the largest share. The healthcare sector benefits from the growing demand for biocompatible materials used in surgical implants, tissue engineering, and drug delivery systems. On the other hand, pharmaceuticals, while smaller in comparison, are emerging rapidly due to increasing investments in biopharmaceutical R&D and a focus on personalized medicine. Growth trends in this segment are significantly driven by advancements in biomaterial technologies, increasing healthcare expenditures, and a rising prevalence of chronic diseases. The demand for sustainable and eco-friendly materials is also boosting the adoption of biomaterials in pharmaceuticals. Innovations such as biodegradable polymers and natural biomaterials are expected to further propel the growth of these segments in the coming years.

Healthcare: Surgical Implants (Dominant) vs. Drug Delivery Systems (Emerging)

Surgical implants represent a dominant area within the healthcare segment of the India biomaterial market. They are crucial for various medical procedures, providing structural support and facilitating healing. The market is characterized by a variety of materials ranging from metals to polymers, chosen for their biocompatibility and mechanical properties. In contrast, drug delivery systems are becoming increasingly important as an emerging segment. They utilize biomaterials to create innovative formulations that enhance the efficacy of drugs while minimizing side effects. As personalized medicine gains traction, the focus on developing advanced drug delivery technologies becomes critical, placing this segment in a growth trajectory driven by research and innovation.

Get more detailed insights about India Biomaterial Market

Key Players and Competitive Insights

The biomaterial market in India is currently characterized by a dynamic competitive landscape, driven by increasing demand for sustainable materials across various industries, including packaging, automotive, and healthcare. Key players such as BASF SE (Germany), DuPont de Nemours Inc (US), and Covestro AG (Germany) are actively positioning themselves through innovation and strategic partnerships. For instance, BASF SE (Germany) has focused on developing bio-based materials that align with environmental regulations, while DuPont de Nemours Inc (US) emphasizes its commitment to sustainability through the introduction of advanced biopolymers. These strategies collectively enhance their competitive edge, fostering a market environment that prioritizes eco-friendly solutions.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The competitive structure of the biomaterial market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they leverage their resources to optimize production processes and enhance product offerings, thereby shaping the overall market dynamics.

In October Covestro AG (Germany) announced a significant investment in a new production facility in India aimed at increasing its capacity for bio-based polycarbonate materials. This strategic move is likely to bolster Covestro's market presence and cater to the growing demand for sustainable materials in the region. The establishment of this facility not only signifies a commitment to local production but also aligns with the broader trend of reducing carbon footprints in manufacturing.

In September DuPont de Nemours Inc (US) launched a new line of biopolymer products specifically designed for the Indian market, targeting the packaging sector. This initiative reflects DuPont's strategy to capitalize on the increasing consumer preference for sustainable packaging solutions. By tailoring its offerings to local needs, DuPont enhances its competitive positioning and addresses the rising demand for environmentally friendly materials.

In August BASF SE (Germany) entered into a partnership with a local startup focused on developing biodegradable materials for the textile industry. This collaboration is indicative of BASF's strategy to innovate through partnerships, allowing it to leverage local expertise and accelerate the development of sustainable solutions. Such alliances are crucial in navigating the complexities of the biomaterial market and responding to evolving consumer preferences.

As of November the competitive trends in the biomaterial market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are playing a pivotal role in shaping the current landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will increasingly hinge on innovation and technological advancements rather than solely on price. The emphasis on supply chain reliability and sustainable practices is likely to redefine competitive strategies, fostering a market environment where adaptability and forward-thinking solutions are paramount.

Key Companies in the India Biomaterial Market include

Industry Developments

The India Biomaterial Market has seen significant developments recently. In June 2023, Novamont announced the launch of new biodegradable materials aimed at reducing plastic waste, aligning with India's focus on sustainable practices. Additionally, Evonik Industries collaborated with local players to enhance their production capabilities for biopolymers, fostering innovation in the sector. Both Corbion and Total Corbion PLA have expanded their footprint in India, reflecting the growing demand for bioplastics in packaging applications.

Notably, in March 2023, Mitsubishi Chemical completed its acquisition of BioAmber's assets, marking a strategic move to enhance their biobased portfolio in the region. NatureWorks has also been investing in Research and Development to scale up Ingeo production within India. As of 2023, Bain Capital has shown interest in the Indian market, diversifying investments towards sustainable materials, signaling positive growth prospects. The valuation of companies like BASF and DuPont in the biopolymer space has increased following these developments, significantly impacting market dynamics.

The Indian government’s push for greener technologies and initiatives like the Plastic Waste Management Rules are also contributing to the burgeoning growth of the biomaterial market.

Future Outlook

India Biomaterial Market Future Outlook

The Biomaterial Market in India is poised for growth at 7.82% CAGR from 2025 to 2035, driven by increasing demand for sustainable materials and advancements in technology.

New opportunities lie in:

  • Development of biodegradable packaging solutions for consumer goods.
  • Investment in R&D for innovative medical implants using biomaterials.
  • Expansion of supply chains for locally sourced biomaterials in construction.

By 2035, the biomaterial market is expected to achieve substantial growth, reflecting evolving consumer preferences and technological advancements.

Market Segmentation

India Biomaterial Market Type Outlook

  • Natural Biomaterials
  • Synthetic Biomaterials
  • Modified Biomaterials

India Biomaterial Market Source Outlook

  • Plant-based
  • Animal-based
  • Microbial-based

India Biomaterial Market End-use Outlook

  • Healthcare
  • Pharmaceuticals
  • Cosmetics

India Biomaterial Market Application Outlook

  • Medical Devices
  • Tissue Engineering
  • Drug Delivery
  • Orthopedics
  • Wound Care

Report Scope

MARKET SIZE 2024 4715.4(USD Million)
MARKET SIZE 2025 5084.14(USD Million)
MARKET SIZE 2035 10796.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.82% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled BASF SE (DE), DuPont de Nemours Inc (US), Covestro AG (DE), Mitsubishi Chemical Corporation (JP), Evonik Industries AG (DE), 3M Company (US), NatureWorks LLC (US), Genomatica Inc (US), Futerro (BE)
Segments Covered Application, Type, Source, End-use
Key Market Opportunities Growing demand for sustainable packaging solutions drives innovation in the biomaterial market.
Key Market Dynamics Rising demand for sustainable materials drives innovation and competition in the biomaterial market.
Countries Covered India
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions